817-442-2020
817-442-2020

Dr. Brett Mueller

Dr. Brett Mueller is a board-certified and fellowship-trained ophthalmologist who specializes in and has performed thousands of cataract and refractive eye surgeries. With advanced fellowship training in refractive surgery through the world college of refractive surgery and visual sciences, he hones a comprehensive range of skill sets needed to diagnose, address, and treat the full spectrum of refractive surgery. He is a 6th generation Texan and is ecstatic to be back in Dallas/Fort Worth and being able to provide his patients better clear, crisp vision with leading surgical and refractive techniques and technology to improve eyesight.

Book Online

Education & Experience

Brett H. Mueller II, D.O., Ph.D. is a Board Certified, fellowship-trained refractive and cataract surgeon. He is a 6th generation Texan. After receiving his undergraduate degree from Texas A&M University, he then received his medical degree and Ph.D. from the University of North Texas Health Science Center.

Dr. Mueller’s scientific work and academic accomplishments enabled him to author over 45 publications and book chapters, present at national and international meetings, and be a recipient of several grants (including an NIH grant). He was then accepted to attend an ophthalmology residency at the University of Louisville, where he developed a reputation for being a leader amongst his colleagues, serving as chief resident, and a skilled surgeon. After finishing residency training, Dr. Mueller then completed a one year refractive, cataract, and anterior segment fellowship through the Refractive Fellowship Network and the World College of Refractive Surgery and Visual Sciences. He now specializes in state-of-the-art laser guided cataract surgery and advanced lens implants that reduce or eliminate the need for glasses. He also specializes in the full spectrum of refractive surgery which includes: modern LASIK, SMILE, EVO-ICLs, Refractive Lens Exchange, PRK, and Cross-Linking.

  • Refractive, Cataract, Anterior Segment Surgical Fellowship at Parkhurst NuVision through the World College of Refractive Surgery
    San Antonio, TX
  • University of Louisville Dept. of Ophthalmology
    Louisville, KY
    Ophthalmology Resident
  • University of Louisville Dept. of Internal Medicine
    Louisville, KY
    Internship in Internal Medicine
  • University of North Texas Health Science Center
    Fort Worth, TX
    Doctor of Osteopathic Medicine
  • University of North Texas Health Science Center
    Fort Worth, TX
    Doctor of Philosophy in Pharmacology and Neuroscience
  • Texas A&M
    College Station, TX
    Bachelor of Science in Biomedical Science

Specialties

Laser Cataract Surgery

Cataracts, which occur as we age, can cause blurry, impaired vision. Dr. Mueller is skilled in removing cataracts to help restore clarity and even enhance vision.

Learn More

Evo Visian ICL™

Dr. Mueller is skilled in enhancing patients’ vision via EVO Visian implantable contact lenses (ICLs), which are placed into your eye without removing any tissue for outcomes similar to LASIK.

Learn More

LASIK

One of the most common vision-correcting refractive surgeries, LASIK improves eyesight by reshaping the cornea using an ultraprecise laser for long-term clarity.

Learn More

SMILE LASIK

Small incision lenticule extraction surgery, commonly known as SMILE, provides patients with similar vision results as LASIK. Dr. Mueller offers this procedure for patients who have thinner corneas, active lifestyles, or otherwise don’t qualify for LASIK surgery.

Learn More

Photorefractive Keratectomy

Photorefractive keratectomy (PRK) is a popular vision correction alternative to LASIK for people with certain cornea or eye issues. Dr. Mueller is experienced with both LASIK and PRK, and these very similar procedures also have nearly identical outcomes.

Learn More

Refractive Lens Exchange (RLE)

Refractive Lens Exchange, or RLE, is a quick outpatient procedure where Dr. Mueller replaces the eye’s natural lens with a vision-enhancing artificial lens. RLE’s outcomes are the same Vision Packages as those we have for premium cataract surgery, and this procedure prevents cataracts as well.

Learn More

Get to Know Dr. Mueller

Dr. Mueller also is an innovator and researcher having received his PhD studying new treatment modalities in the field of Ophthalmology. He is quickly making a name for himself and has over 45 scientific articles, papers, and abstracts published at both national and international meetings. At NuVision, he has served as both a principal investigator and sub-investigator on numerous industry-sponsored and FDA clinical trials. Dr. Mueller’s passion has always been to improve the field of ophthalmology and refractive surgery, and he looks forward to continuing to advance his field for his patients for many years to come.

Book Online

Open Letter to Patients

I remember distinctly the exact time when I knew that I wanted to be an ophthalmologist. It was June 2007, and I had just completed a ten-day medical mission trip to Guatemala, where we served over 2000 patients. These patients came to our clinic seeking something very foreign to them: medical care. I recall one elderly man, blinded by cataracts, who took the arduous journey of over eight hours from the Guatemalan hills, with his grandson holding his hand, guiding each step. Upon entering the patient room with the general surgeon, we had to apologize to this elderly man and his grandson, because there was no ophthalmologist at the facility, so we could not remove his cataracts. As the look of joyous hope turned to despairing sadness, the grandfather communicated through tear-filled eyes that all he wanted to do was to see the sunrise one last time, behold the beauty of nature, and look into the eyes of his grandson. As they left, I felt an overwhelming sense of compassion, as I would have given anything to have been able to help him that day.
 
This story resonates with me, because I see this elderly man in every single one of the patients that I treat on a daily basis. Whether it be people who come in that are not able to experience life to their fullest because of their cataracts, or blinded because of their near-sightedness or astigmatism. I love being able to offer solutions to YOU for these conditions, and see that look of joy come across your face when you discover that there is a cure, that you can live life with clear, crisp vision.
 
These moments are even more special to me when I get to provide them for my family. My mother just recently had laser cataract surgery, and can now see 20/15 at distance, and read her book without the need of reading glasses. She describes her vision as like how it was when she was 20 years old. My sister, who was blinded by her nearsightedness since she was 3 just recently had the EVO-Visian ICL procedure performed on her, and she can now see 20/10 without the aid of glasses or contacts and describes everything in her world being in HD. These stories happen all the time with my patients, and I feel very blessed and fortunate to be able to share these moments with you.
 
As a refractive cataract surgeon, I daily witness patients and family members frustrated by loss of eyesight due to cataracts, or the debilitation from needing to be dependent upon prosthetic eyewear. Such experiences always bring me back to my experiences in Guatemala, but now, instead of telling this grandfather and grandson that there is nothing we can do, I can now say, “There is something that I can do … I can help you.”

Q&A With Dr. Mueller

Where are you from originally, and what other places have you lived?
I am a 6th generation Texan, born and raised in San Antonio Texas. But spent 7 years going to medical school and getting my PhD in Dallas/Fort Worth and fell in love with DFW. I am happy to be back and cant wait to help the people in DFW with their vision

Please tell us more about where you live now and/or the people and pets you live with.
I am married to my wife Deanna Mueller, and I have three kids: Brett Mueller III, Daniel Mueller, and Autumn Mueller

Please list the hobbies, interests, or unique talents you would like us to share publicly.
I am an avid cyclist, and raced on the Texas A&M cycling team. I also love running and being outdoors.

Is there any community/volunteer/service work that you participate in?
I do medical mission work where I travel to 3rd world countries performing cataract surgery on people that do not have access to medical or surgical care. I work with the Rotary club where we go to rural towns in Mexico performing cataract surgery on patients where they do not have access to medical or surgical care. Also I have involved with the Himalayan Cataract Project that has the goal of curing needless blindness with high-quality, cost effective eye care in underserved areas of the world. It gives me great satisfaction utilizing my surgical training to help those that are less fortunate. Also starting a foundation with STAAR surgical where we are going to provide refractive surgery for individuals with special needs and those that are economically disadvantaged in the US. In addition, AVI is also partnering with the Community Eye Clinic in Fort Worth and Cornerstone Fort Worth to provide cataract surgery for patients who do not have medical insurance and that are below 250% the federal poverty level.

Do you speak any foreign languages?
I speak English and Spanish

What differentiates you from your competitors?
I have advanced specialized fellowship training that encompasses the full spectrum of refraction surgery. I am an expert in all 8 of the different refractive procedures that are performed world wide.

Is there a certain type of patient, or a subset of patients, that you particularly like working with?
Patients seeking a cure from their glasses and contacts. Also helping patients by performing modern cataract surgery and helping them achieve glasses independence after cataract surgery

Why do you think Alliance Vision Institute is special/unique?
AVI is going to be on the forefront and cutting edge in terms of refractive surgery and cataract surgery. We are world renowned experts in this space and we look forward to helping people be able to see clearly and crisply without the need of glasses and contacts.

What are you most excited about to be working at Alliance Vision Institute?
It is a world class team that has come together to provide the very best care in terms of refractive surgery and cataract surgery in the world.

Do you believe there are technologies or services at Alliance Vision Institute that patients can’t find elsewhere?
We have the best in terms of surgeons and the different technologies that are available in ophthalmology

Why would a patient choose Alliance Vision Institute (over another provider) for their vision needs?
We have world class fellowship trained surgeons and the best in terms of the different technologies that are available.

  • Board Certified by the American Board of Ophthalmology
  • Fellow of the American Academy of Ophthalmology
  • American Society of Cataract and Refractive Surgery
  • Refractive Surgery Alliance
  • American-European Congress of Ophthalmic Surgery
  • Adjunct Clinical Assistant Professor at the University of Incarnate Word School of Osteopathic
  • Medicine
  • Adjunct Clinical Assistant Professor at the University of Incarnate Word School of Optometry
  • Adjunct Assistant Professor at the University of North Texas Health Science Center
  • 2022 – Top Doctors in Ophthalmology: Castle Connolly Rising Star
  • 2021 – AECOS/Cedars Aspens Mentorship Forum
  • 2020 – American Academy of Ophthalmology Board Certification
  • 2018 – Dr. Melvyn Koby Educational Excellence Award
    Awarded to the top graduating ophthalmology resident at the University of Louisville.
  • 2016 – Heed Resident Retreat 2016 Attendee
    Selected to attend this retreat amongst other residents in the country on
    the basis of academic achievements.
  • 2014 – University of North Texas Health Science Center Chancellor’s Award
    Awarded to the top graduate for research accomplishments at UNTHSC amongst all the students graduating in the medical school, graduate school, school of public health, and school of health professions.
  • 2014 – University of North Texas Health Science Center Graduate Student of the Year Award
    Awarded to the top graduate student at UNTHSC.
  • 2014 – Texas College of Osteopathic Medicine Research Award
    Awarded to the medical student who had the greatest achievements in research.
  • 2014 – North Texas Eye Research Institute Graduate Student of the Year Award
    Awarded to the top graduate student at UNTHSC who performed
    research in ophthalmology.
  • 2014 – University of North Texas Health Science Center – Research Appreciation Day
    • Awarded first place for the best poster presentation in the TCOM honors
      student category.
    • Awarded first place for the best oral presentation.
    • Awarded second place for a poster presentation in the Graduate School
      of Biomedical Science category.
  • 2008 – 2014 – Sigma, Sigma Phi National Honorary Osteopathic Service Fraternity
    Competitive service fraternity where members inducted to this fraternity have demonstrated a commitment to academic excellence and community
    service.
  • 2012 – University of North Texas Health Science Center – Research Appreciation Day
    Awarded first place for the best poster presentation in the Graduate School of Biomedical Science category.
  • 2012 – Sigma Xi Scientific Research Society
    Inducted as a member of this scientific society because of recognition of my scientific accomplishments.
  • 2011 – University of North Texas Health Science Center – Research Appreciation Day
    • Awarded first place for the best poster presentation in the medical student category.
    • Awarded second place for the poster presentation in the North Texas Eye Research Institute category.
  • 2010 – Medical School Governing Association “Member of the Year”
    Voted on by my peers to be the MSGA member of the year given mywork and commitment to the organization and my fellow medical school students.
  • 2010 – Association for Research in Vision and Ophthalmology Travel Grant
    Awarded to the first author of an ARVO abstract.
  • 2008 & 2009 – TCOM Alumni Association – Award of Academic Excellence
    Awarded to the top 5 medical school students each year.
  • 2007 – 2009 TCOM Dean’s List Each Semester (x4)
    Awarded to the students in the top 10% of their medical school class after completion of each semester.
  • Principal Investigator: Post-Approval Study of the PanOptix Trifocal Lens in Patients Who Have Had Post Refractive Myopic Laser Vision Correction Surgery.
  • Principal Investigator: Post-Approval Study of the Vivity EDOF Lens in Patients Who Have Had Post Refractive Hyperopic Laser Vision Correction Surgery.
  • Sub-Investigator: FDA Clinical Trial Investigating the EVO Intraocular Collamer Lens (ICL)
  • Sub-Investigator: Yukon Study, Post-Market Evaluation of Surgeon Feedback of TECNIS Toric II Intraocular Lens (IOL). NXGT-201-TTL2. 2020
  • Sub-Investigator: Post-Approval Study of the TECNIS Symfony Toric Lenses. 2019.
  • Sub-Investigator: A Phase 3, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of AGN-190584 in Participants with Presbyopia. 2018.
  • Sub-Investigator: A Prospective Clinical Trial to Evaluate the Safety and Effectiveness of Model SC9 Posterior Chamber Silicone Intraocular Lens for Primary Implantation in the Capsular Bag of the Eye for Visual Correction of Aphakia Secondary to Removal of a Cataractous Lens in Adult Patients With or Without Presbyopia. The IOL is Intended to Improve Near and Intermediate Vision as Compared to a Legally Marketed IOL. 2018.
  • Sub-Investigator: Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5%. San Antonio, Texas. 2018.
  • Sub-Investigator: iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study. San Antonio, Texas. 2019

 

Original & Peer-Reviewed Publications

  1. Saenz B, Ferguson TJ, Abraham N, Mueller BH, Parkhurst GD. Evaluation of Same-Day versus Next-Day Implantation of Intracanalicular Dexamethasone for the Control of Postoperative Inflammation and Pain Following Cataract Surgery. Clin Ophthalmol. 2021 Dec 7;15:4615-4620. doi: 10.2147/OPTH.S334297. PMID: 34916773; PMCID: PMC8669496.
  2. Mueller B. Very High-Frequency Ultrasound Improves ICL Sizing Precision. OphthalmologyTimes.com, pages 30-31, December 2021
  3. Mueller B. Video: ArcScan a ‘game changer’ for ICL sizing. Healio News, December 6, 2021
  4. Mueller B. The Need for More Refractive Surgeons and Refractive Surgery Fellowships. MillennialEye. 2020 Janary/February.
  5. Saenz B & Mueller B. Scleral Lenses or CXL: Which Should Come First? The answer is…it depends. Modern Optometry. 2020 January/February.
  6. Saenz B, Mueller B, Vanrachack A, Davies B. Thyroid Eye Disease in Your Exam Lane. Review of Optometry. 2019 October.
  7. Hadayer A, Mueller B, Adeniran J, Barr C. Outcomes of Surgically Managed Proliferative Diabetic Retinopathy. Journal of VitreoRetinal Diseases. 2018 November; 2(6):338-342.
  8. Puri S, Duff SM, Mueller B, Prendes M, Clark J. Hairpulling causing vision loss: a case report. Orbit. 2018 May 4:1-4. PubMed PMID: 29727255.
  9. Mugavin M, Mueller BH 2nd, Desai M, Golnik KC. Optic Neuropathy As the Initial Presenting Sign of N-methyl-d-aspartate (NMDA) Encephalitis. Neuroophthalmology. 2017 Jan 11;41(2):90-93. doi: 10.1080/01658107.2016.1262431. eCollection 2017 Apr. PubMed PMID: 28348631; PubMed Central PMCID: PMC5354102.
  10. Stankowska DL, Mueller BH 2nd, Oku H, Ikeda T, Dibas A. Neuroprotective effects of inhibitors of Acid-Sensing ion channels (ASICs) in optic nerve crush model in rodents. Curr Eye Res. 2018 Jan;43(1):84-95. PubMed PMID: 29111855.
  11. Mueller B. From Neurology to Glaucoma. Glaucoma Today. 2017 May/June.
  12. Ellis DZ, Li L, Park Y, He S, Mueller B, Yorio T. Sigma-1 Receptor Regulates Mitochondrial Function in Glucose- and Oxygen-Deprived Retinal Ganglion Cells. Invest Ophthalmol Vis Sci. 2017 May 1;58(5):2755-2764. doi: 10.1167/iovs.16-19199. PubMed PMID: 28549090.
  13. Blackburn R, Mueller BH, Ramasubramanian A. A Stepwise Approach to the Ocular Manifestations of Graft-vs-Host Disease. Eyenet Magazine. 2017 May 35-37.
  14. Mugavin M, Mueller BH 2nd, Desai M, Golnik KC. Optic Neuropathy As the Initial Presenting Sign of N-methyl-d-aspartate (NMDA) Encephalitis. Neuroophthalmology. 2017 Jan 11;41(2):90-93. doi: 10.1080/01658107.2016.1262431. eCollection 2017 Apr. PubMed PMID: 28348631; PubMed Central PMCID: PMC5354102.
  15. Park YH, Mueller BH 2nd, McGrady NR, Ma HY, Yorio T. AMPA receptor desensitization is the determinant of AMPA receptor mediated excitotoxicity in purified retinal ganglion cells. Exp Eye Res. 2015 Mar;132:136-50. doi: 10.1016/j.exer.2015.01.026. Epub 2015 Jan 30. PubMed PMID: 25643624.
  16. Stankowska DL, Minton AZ, Rutledge MA, Mueller BH 2nd, Phatak NR, He S, Ma HY, Forster MJ, Yorio T, Krishnamoorthy RR. Neuroprotective effects of transcription factor brn3b in an ocular hypertension rat model of glaucoma. Invest Ophthalmol Vis Sci. 2015 Jan 13;56(2):893-907. doi: 10.1167/iovs.14-15008. PubMed PMID: 25587060; PubMed Central PMCID: PMC4321399.
  17. Mueller BH 2nd, Park Y, Ma HY, Dibas A, Ellis DZ, Clark AF, Yorio T. Sigma-1 receptor stimulation protects retinal ganglion cells from ischemia-like insult through the activation of extracellular-signal-regulated kinases 1/2. Exp Eye Res. 2014 Nov;128:156-69. doi: 10.1016/j.exer.2014.10.007. Epub 2014 Oct 8. PubMed PMID: 25305575.
  18. Mueller BH 2nd, Park Y, Daudt DR 3rd, Ma HY, Akopova I, Stankowska DL, ClarkAF, Yorio T. Sigma-1 receptor stimulation attenuates calcium influx through activated L-type Voltage Gated Calcium Channels in purified retinal ganglion cells. Exp Eye Res. 2013 Feb;107:21-31. doi: 10.1016/j.exer.2012.11.002. PubMed PMID: 23183135.
  19. Minton AZ, Phatak NR, Stankowska DL, He S, Ma HY, Mueller BH, Jiang M, Luedtke R, Yang S, Brownlee C, Krishnamoorthy RR. Endothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma. PLoS One. 2012;7(8):e43199. doi: 10.1371/journal.pone.0043199. PubMed PMID: 22916224; PubMed Central PMCID: PMC3423444.
  20. Das HK, Tchedre K, Mueller B. Repression of transcription of presenilin-1 inhibits γ-secretase independent ER Ca²⁺ leak that is impaired by FAD mutations. J Neurochem. 2012 Aug;122(3):487-500. doi: 10.1111/j.1471-4159.2012.07794.x. PubMed PMID: 22607268.
  21. Daudt DR 3rd, Mueller B, Park YH, Wen Y, Yorio T. Methylene blue protects primary rat retinal ganglion cells from cellular senescence. Invest Ophthalmol Vis Sci. 2012 Jul 10;53(8):4657-67. doi: 10.1167/iovs.12-9734. PubMed PMID:22661471.

 

Book Chapters

  1. Park Y, Ellis D, Mueller B, Stankowska D, Yorio T. Principles of Ocular Pharmacology. Handb Exp Pharmacol. 2017;242:3-30. doi: 10.1007/164_2016_25. PubMed PMID: 27730396.
  2. Brett H. Mueller II, Dorota L. Stankowska and Raghu R. Krishnamoorthy (2011). Neuroprotection in Glaucoma, Glaucoma – Basic and Clinical Concepts, Dr Shimon Rumelt (Ed.), ISBN: 978-953-307-591-4, InTech, DOI: 10.5772/18465. Available from: http://www.intechopen.com/books/glaucoma-basic-and-clinical-concepts/neuroprotection-in-glaucoma

 

Oral Presentations (selected from national or international meetings only)

  1. Mueller BH, Saenz B, Abraham N, Cavazos C, Parkhurst G. Toric Implantable Collamer Lenses: Early United States Experience. ASCRS Annual Meeting, May 16-17, 2020.
  2. Uncertainties in Fellowship and Beyond | Priyanka Sood, MD; Neel Desai, MD; Lorraine Provencher, MD; Joshua Frenkel, MD, MPH; Brett Mueller, D.O., Ph.D. Millenial Live, Louisville, KY, September 2019
  3. Dibas A, Stankowska D, Mueller B, Hidehiro O, Yorio T. Neuroprotective Effects of Inhibitors of Acid-Sensing Ion Channels (ASIC) in Optic Nerve Crush Model in Rodents. ARVO Annual Meeting, Abstract Number 3405. Baltimore, MD. May 2017
  4. Mueller BH, Park Y, Ma H, Yorio T. Sigma-1 Receptor Stimulation Protects Purified RGCs from Ischemic Insult through the Phosphorylation of Extracellular Signal Regulated Kinase 1/2. ARVO Annual Meeting, Abstract Number 3699. Seattle, WA. May 2013
  5. Mueller BH, Dibas A, Park Y, Ma H, Oku H, Fukuhara M, Kurimoto T, Ikeda T, Clark AF, Yorio T. Prolonged NMDA Treatment Induces Neuroprotective Pathways in Primary Retinal Ganglion Cells through Phosphorylation of cAMP Response Element-Binding Protein (CREB). XX Biennial Meeting of the International Society for Eye Research (ISER). Abstract number A-412-0006-00719. Berlin, Germany. July 21-25, 2012

 

Research Poster Presentation

  1. Mueller B, Raj R; Bhola R. Wind Instruments: A Cause of Chronic Elevation of Intraocular Pressure in a Pediatric Population. ARVO Annual Meeting, Abstract Number 5333 – B0430. Baltimore, MD. May 2017
  2. Godwin K, Mueller BH, Soltau JB, Mohay-Ambrus J, DeMarco P. Modeling the Pattern Electroretinogram in Patients with Primary Open-Angle Glaucoma. ARVO Annual Meeting, Abstract Number 4888 – B0277. Baltimore, MD. May 2017
  3. Mueller BH, Park Y, Ma HY, Yorio, T. Prolonged NMDA Stimulation Induces Neuroprotective Pathways and Enhances Survivability of Primary Retinal Ganglion Cells. ARVO Annual Meeting, Session Number 242. Orlando, FL. May 2014
  4. Park Y, Mueller BH, McGrady N, Dibas, A.; Yorio, T. Retinal Ganglion Cells Are Resistant to AMPA Receptor Mediated Excitotoxicity. ARVO. Orlando, FL. May 2014
  5. Park Y, Mueller B, Ma HY, Yorio T. Stimulation of the AMPA Receptor in Retinal Ganglion Cells Increases Phosphorylation of CREB. ARVO Annual Meeting. Seattle, WA. May 2013
  6. Mueller B, Park Y, Ma H, Yorio T. Inhibition of NMDA Induced Calcium Ion Influx in Retinal Ganglion Cells through NMDA Stimulation. ARVO Annual Meeting, Session Number 478. Fort Lauderdale, FL. May 2012.
  7. Minton A, Phatak N, Ma H, Stankowska D, He S, Mueller B, Krishnamoorthy R. Endothelin B Receptors Contribute to Neurodegeneration in a Rodent Model of Glaucoma. ARVO Annual Meeting, Session Number 479. Fort Lauderdale, FL. May 2012.
  8. Minton A, Phatak N, Mueller B, Ma H, Jian M, He S, Krishnamoorthy R. Neurodegenerative Effects of Endothelin B Receptor in a Rodent Model of Glaucoma. ARVO Annual Meeting, Session Number 312. Fort Lauderdale, FL. May 2011.
  9. Mueller B, Krishnamoorthy R, Daudt D, Ma H, Yorio T. Interaction of Sigma-1 Receptors with Voltage Gated Calcium Channels Attenuates Calcium Response in Primary Retinal Ganglion Cells. ARVO Annual Meeting, Session Number 312. Fort Lauderdale, FL. May 2011.
  10. Yorio T, Daudt D, Mueller B. Effects of Sigma-1 Receptors on Mitochondrial Fusion in Retinal Ganglion Cells. ARVO Annual Meeting, Session Number 456. Fort Lauderdale, FL. May 2011.
  11. Mueller B, Krishnamoorthy R, Yorio T. Sigma-1 Receptor Expression in Retinal Ganglion Cells after Ocular Hypertension in Rats. ARVO Annual Meeting, Session Number 520. Fort Lauderdale, FL. May 2010.
  12. Krishnamoorthy R, Ma H, Mueller B. Increased Endothelin B Receptor Expression in Retinal Ganglion Cells after Ocular Hypertension in Rats. ARVO Annual Meeting, Session Number 520. Fort Lauderdale, FL. May 2010.
  13. Mueller B, Page R. Medicare 2005 Demonstration Project: Patient Reporting of Nausea Symptoms and its Impact on Improving Quality of Patient Care. Texas Society of Medical Oncology Annual Meeting. Houston, TX. October 2007.
  14. Fletcher S, Mueller B. Neurosurgical Management of Children with Persistent Vomiting or Syncope as the Sole Finding in Chiari Syndrome. The American College of Osteopathic Surgeons National Meeting. San Francisco, CA. October 2007.
  15. Mueller B, Page R. Medicare 2005 Demonstration Project: Patient Reporting of Nausea Symptoms and its Impact on Improving Quality of Patient Care. American Society for Cancer Oncology Conference. Chicago, IL. ASCO 2007 Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 6615.
  16. Osmulski P, Mueller B, Gaczynska M. The Ubiquitin Family. Summer FASEB Research Conference. Saxton River, VT. July 2006.
  17. Osmulski P, Mueller B, Tan X, Gaczynska M. Proteases-Related Molecular Signature of Breast Cancer. Era of Hope DOD Breast Cancer Research Program Meeting. Philadelphia, PA. June 2006.
  18. Mueller B, Osmulski P, Gaczynska M. Proteasome-Related Molecular Signature of Breast Cancer. Annual Retreat of San Antonio Cancer Institute/Genomic Integrity and Carcinogenesis Program. San Antonio, TX. May 2005.

 

Ophthalmology Online Lectures

  1. Mueller B. Mentoring Session with Brett H. Mueller II, D.O., Ph.D. Young MD Connect. April 8, 2021

 

Ophthalmology Podcasts

  1. Mueller B, Zhu D, and Shamie N. Getting Comfortable with Advanced Presbyopia-Correcting Technologies. Presbyopia Unlocked. Eyetube, BMC Today. 4/29/2020
  2. Saenz B and Mueller B. Eye Health and Surgical Outcomes, Treating Keratoconus, Specializing in Ocular Aesthetics. Eyetube, The MODPOD. Episode 11. 2/25/2020.

You Deserve the Clearest Vision. Achieve it with Alliance Vision Institute.

Vision Self-Exam

The doctors at Alliance Vision Institute have reviewed and approved this content.